188 results
Page 7 of 10
8-K
EX-99.1
v344gye4x2jto
9 Apr 07
Discovery Labs Announces Completion of $30 Million Registered Direct Offering
12:00am
8-K
EX-99.1
e7dia029
3 Apr 07
Discovery Labs to Raise $30 Million in Registered Direct Offering
12:00am
424B5
tb0bvge1fd sc0gn0lvd
3 Apr 07
Prospectus supplement for primary offering
12:00am
8-K
EX-99.1
7w7z 17b7rv
28 Feb 07
Discovery Labs Reports Fourth Quarter 2006 Financial Results
12:00am
8-K
EX-99.1
o6ismjool0hwqceodruw
9 Nov 06
Discovery Labs Reports Third Quarter 2006 Financial Results
12:00am
8-K
EX-99.1
c1c7jwssfn0u3p9
26 Oct 06
Entry into a Material Definitive Agreement
12:00am
8-K
EX-99.1
p81ol1cpn3f9w2tdll1
11 Oct 06
Discovery Labs Announces Topline Results of Surfaxin® Phase 2 Clinical Trial for the Prevention and Treatment of BPD
12:00am
8-K
EX-99.1
6ft89t7zzb
28 Sep 06
Discovery Labs Updates Progress on Manufacturing Remediation and Surfaxin® FDA Regulatory Matters
12:00am
8-K
EX-99.1
yq2mql0e3
2 Aug 06
Discovery Labs Reports Second Quarter 2006 Financial Results
12:00am
8-K
EX-99.1
3713xeo20ip3 iss3h2
27 Jun 06
Discovery Labs Reports Progress on its Surfactant Manufacturing Remediation
12:00am
8-K
EX-99.1
189amf59s5m
22 Jun 06
Discovery Labs Retains Jefferies & Company to Assist in the Evaluation of Potential Strategic Alternatives
12:00am
8-K
EX-99.1
ag7c 03eting8n
16 Jun 06
Discovery Labs’ SurfaxinÒ Granted Orphan Drug Designation for the Prevention of Bronchopulmonary Dysplasia
12:00am
8-K
EX-99.1
vwkoquv
7 Jun 06
Other Events
12:00am
424B3
v68ncij1nqhw1 n31r5
12 May 06
Prospectus supplement
12:00am
8-K
EX-99.1
ux3tgxpcv d3ufhqiy
4 May 06
Discovery Labs Announces Corporate Reorganization and Personnel Reduction
12:00am